Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6556-6566

  Dorigo, Oliver ^a,b   Gil, Jose S ^a   Gallaher, Sean D ^a   Tan, Brenton T ^c   Castro, Maria G ^d   Lowenstein, Pedro R ^d   Calos, Michele P ^c   Berk, Arnold J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALBUMIN; CELL NUCLEUS ANTIGEN; CRE RECOMBINASE; CYCLINE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA FLANKING REGION; EPIGENETICS; EPISOME; EPSTEIN BARR VIRUS; HELPER CELL; HELPER DEPENDENT ADENOVIRUS; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MAMMAL CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS EPISOME; VIRUS HYBRID; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CELL LINE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HELPER VIRUSES; HEPATOCYTES; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, NUDE; PLASMIDS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 2642545574     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6556-6566.2004     Document Type: Article

References (46)

1. Benihoud, K., P. Yeh, and M. Perricaudet. 1999. Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 10:440-447.
2. Bhaumik, S., and S. S. Gambhir. 2002. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc. Natl. Acad. Sci. USA 99:377-382.
3. Black, J., and J. M. Vos. 2002. Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts. Gene Ther. 9:1447-1454.
4. Ceccarelli, D. F., and L. Frappier. 2000. Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus. J. Virol. 74:4939-4948.
5. Chen, L., M. Anton, and F. L. Graham. 1996. Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre. Somat. Cell Mol. Genet. 22:477-488.
6. Cormack, B. P., R. H. Valdivia, and S. Falkow. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
7. Ehrhardt, A., and M. A. Kay. 2002. A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo. Blood 99:3923-3930.
8. Gahery-Segard, H., F. Farace, D. Godfrin, J. Gaston, R. Lengagne, T. Tursz, P. Boulanger, and J. G. Guillet. 1998. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J. Virol. 72:2388-2397.
9. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
10. Haase, S. B., and M. P. Calos. 1991. Replication control of autonomously replicating human sequences. Nucleic Acids Res. 19:5053-5058.
11. Harui, A., S. Suzuki, S. Kochanek, and K. Mitani. 1999. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73:6141-6146.
12. Heinzel, S. S., P. J. Krysan, C. T. Tran, and M. P. Calos. 1991. Autonomous DNA replication in human cells is affected by the size and the source of the DNA. Mol. Cell. Biol. 11:2263-2272.
13. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
14. Hoess, R. H., and K. Abremski. 1984. Interaction of the bacteriophage P1 recombinase Cre with the recombining site loxP. Proc. Natl. Acad. Sci. USA 81:1026-1029.
15. Hung, S. C., M. S. Kang, and E. Kieff. 2001. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl. Acad. Sci. USA 98:1865-1870.
16. Khan, G., E. M. Miyashita, B. Yang, G. J. Babcock, and D. A. Thorley-Lawson. 1996. Is EBV persistence in vivo a model for B-cell homeostasis? Immunity 5:173-179.
17. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
18. Krysan, P. J., and M. P. Calos. 1993. Epstein-Barr virus-based vectors that replicate in rodent cells. Gene 136:137-143.
19. Krysan, P. J., S. B. Haase, and M. P. Calos. 1989. Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9:1026-1033.
20. Langle-Rouault, F., V. Patzel, A. Benavente, M. Taillez, N. Silvestre, A. Bompard, G. Sczakiel, E. Jacobs, and K. Rittner. 1998. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J. Virol. 72:6181-6185.
21. Lee, C. G., W. D. Vieira, I. Pastan, and M. M. Gottesman. 2001. An episomally maintained MDR1 gene for gene therapy. Hum. Gene Ther. 12:945-953.
22. Lei, D. C., K. Kunzelmann, T. Koslowsky, M. J. Yezzi, L. C. Escobar, Z. Xu, A. R. Ellison, J. M. Rommens, L. C. Tsui, M. Tykocinski, and D. C. Gruenert. 1996. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther. 3:427-436.
23. Leight, E. R., and B. Sugden. 2000. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10:83-100.
24. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwvald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
25. Middleton, T., and B. Sugden. 1994. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol. 68:4067-4071.
26. Miyashita, E. M., B. Yang, K. M. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601.
27. Parks, R. J., L. Chen, M. Anton, U. Sankar, M. A. Rudnicki, and F. L. Graham. 1996. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 93:13565-13570.
28. Parks, R. J., and F. L. Graham. 1997. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol. 71:3293-3298.
29. Postic, C., and M. A. Magnuson. 2000. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26:149-150.
30. Reichel, M. B., R. R. Ali, A. J. Thrasher, D. M. Hunt, S. S. Bhattacharya, and D. Baker. 1998. Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther. 5:1038-1046.
31. Reisman, D., J. Yates, and B. Sugden. 1985. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5:1822-1832.
32. Schiedner, G., N. Morral, R. J. Parks, Y. Wu, S. C. Koopmans, C. Langston, F. L. Graham, A. L. Beaudet, and S. Kochanek. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:180-183.
33. Sclimenti, C. R., A. S. Neviaser, E. J. Baba, L. Meuse, M. A. Kay, and M. P. Calos. 2003. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice. Biotechnol. Prog. 19:144-151.
34. Tan, B. T., L. Wu, and A. J. Berk. 1999. An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency. J. Virol. 73:7582-7589.
35. Tao, N., G. P. Gao, M. Parr, J. Johnston, T. Baradet, J. M. Wilson, J. Barsoum, and S. E. Fawell. 2001. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol. Ther. 3:28-35.
36. Thomas, C. E., G. Schiedner, S. Kochanek, M. G. Castro, and P. R. Lowenstein. 2000. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proc. Natl. Acad. Sci. USA 97:7482-7487.
37. Umana, P., C. A. Gerdes, D. Stone, J. R. Davis, D. Ward, M. G. Castro, and P. R. Lowenstein. 2001. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat. Biotechnol. 19:582-585.
38. Wade-Martins, R., R. E. White, H. Kimura, P. R. Cook, and M. R. James. 2000. Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat. Biotechnol. 18:1311-1314.
39. Wang, Y., J. E. Finan, J. M. Middeldorp, and S. D. Hayward. 1997. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 236:18-29.
40. Witherell, G. W., and E. Wimmer. 1994. Encephalomyocarditis virus internal ribosomal entry site RNA-protein interactions. J. Virol. 68:3183-3192.
41. Yang, Y., F. A. Nunes, K. Berenesi, E. E. Furth, E. Gonezol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
42. Yant, S. R., A. Ehrhardt, J. G. Mikkelsen, L. Meuse, T. Pham, and M. A. Kay. 2002. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat. Biotechnol. 20:999-1005.
43. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
44. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-815.
45. Zhou, H., L. Pastore, and A. L. Beaudet. 2002. Helper-dependent adenoviral vectors. Methods Enzymol. 346:177-198.
46. Zou, L., P. Yotnda, T. Zhao, X. Yuan, Y. Long, H. Zhou, and K. Yang. 2002. Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain. J. Cereb. Blood Flow Metab. 22:959-970.